Switching medical supplies (ppe, syringes) sourcing from India to Thailand

Buyers comparing India and Thailand for medical supplies (ppe, syringes) are really comparing two very different duty stacks. Goods from India clear at an effective 21%, while Thailand clears the same category at 3% — about $18,990 a year at $100,000 of imports. For a category this exposed to surcharges, the sourcing map is effectively a pricing map. The breakdown below itemises both duty stacks so the figure is auditable, not asserted.

How the tariff stacks compare

Start with the two duty stacks side by side. Sourced from India, the goods face a 3% Most-Favoured-Nation base duty and a 18% negotiated bilateral rate on its medical supplies (ppe, syringes), an effective 21% once the $49.74 in processing fees are added. From Thailand, the entry is assessed a 3% Most-Favoured-Nation base duty on its medical supplies (ppe, syringes), an effective 3% once the $49.74 in processing fees are added. The $49.74 in processing and harbor fees is the same on both sides, leaving the duty layers as the only mover of the gap. That leaves a $1,899.00 gap on every $10,000 of goods, driven entirely by the 18% spread in effective duty rate. That same per-dollar gap is about $4,748 on a $25,000 order and $18,990 on $100,000 of annual volume. On a $25,000 purchase order that is about $4,748 of duty difference — the kind of figure that shows up directly in a quarter's gross margin.

Trade context

medical supplies (ppe, syringes) — Surgical masks, N95 respirators, Medical gloves, and Syringes and similar goods — falls under HTS 3926, 6210, 9018.31, 9018.32. For medical supplies (ppe, syringes), where buyers reorder frequently, the duty rate compounds into one of the largest controllable costs on the P&L. India, in Asia-Pacific, ships the US mainly pharmaceutical ingredients, generic drugs, and clothing garments. A bilateral deal swaps India's Section 122 surcharge for a negotiated rate, reshaping how its medical supplies (ppe, syringes) stack is built. Thailand, in Asia-Pacific, ships the US mainly consumer electronics, auto parts components, and rubber. Thailand trades without a special US agreement, so column-1 rates and every surcharge apply to its medical supplies (ppe, syringes) in full. Because both sit in Asia-Pacific, a switch barely changes the freight picture and mostly changes the duty bill. For a buyer committed to India, Thailand is a concrete diversification target whose tariff math is settled and whose remaining diligence is commercial. Because surcharges have stacked rates well above their statutory base, country of origin has become a first-order cost driver for medical supplies (ppe, syringes) rather than a footnote.

Recommendation

Anchor your own volume to these tiers: $9,495 at $50,000, $47,475 at $250,000, $189,900 at $1,000,000, and about $18,990 at $100,000. The numbers come straight from the landed-cost engine, with product cost and shipping fixed across both origins to isolate the tariff difference. These figures reflect tariff and fee savings only, assuming equal product cost — your actual landed cost also depends on price and freight, which vary by supplier. Read the $18,990 as a transition budget — if re-sourcing to Thailand costs less than the annual saving, it pays back inside a year. Diligence on Thailand is commercial, not regulatory: supplier capacity, MOQ, tooling and re-qualification cost — the duty advantage itself is already settled above. Re-run the figures close to your decision: the duty landscape for medical supplies (ppe, syringes) has shifted repeatedly through the year. Use the Tariff Savings Finder to test your real numbers and see alternatives beyond Thailand.